Follow
Nathan M. Palmer
Nathan M. Palmer
PhD Candidate Computational Social Science, George Mason University
Verified email at masonlive.gmu.edu
Title
Cited by
Cited by
Year
Getting at systemic risk via an agent-based model of the housing market
J Geanakoplos, R Axtell, DJ Farmer, P Howitt, B Conlee, J Goldstein, ...
American Economic Review 102 (3), 53-58, 2012
2672012
Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy
AM Moreno, N Palmer, F Alemán, G Chen, A Pla, N Jiang, W Leong Chew, ...
Nature biomedical engineering 3 (10), 806-816, 2019
962019
Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice
AM Moreno, F Alemán, GF Catroli, M Hunt, M Hu, A Dailamy, A Pla, ...
Science translational medicine 13 (584), eaay9056, 2021
742021
An agent-based model of the housing market bubble in metropolitan washington dc
R Axtell, JD Farmer, J Geanakoplos, P Howitt, E Carrella, B Conlee, ...
Benjamin and Goldstein, Jon and Hendrey, Matthew and Kalikman, Philip and …, 2014
482014
Regulation of the embryonic cell cycle during mammalian preimplantation development
N Palmer, P Kaldis
Current topics in developmental biology 120, 1-53, 2016
342016
Discovery of a chemical probe for PRDM9
A Allali-Hassani, MM Szewczyk, D Ivanochko, SL Organ, J Bok, JSY Ho, ...
Nature communications 10 (1), 5759, 2019
302019
Translating CRISPR-Cas therapeutics: approaches and challenges
LS Tay, N Palmer, R Panwala, WL Chew, P Mali
The CRISPR Journal 3 (4), 253-275, 2020
272020
Diverse roles for CDK‐associated activity during spermatogenesis
N Palmer, SZA Talib, P Kaldis
FEBS letters 593 (20), 2925-2949, 2019
242019
Less-well known functions of cyclin/CDK complexes
N Palmer, P Kaldis
Seminars in cell & developmental biology 107, 54-62, 2020
222020
A novel function for CDK2 activity at meiotic crossover sites
N Palmer, SZA Talib, P Singh, CMF Goh, K Liu, JC Schimenti, P Kaldis
PLoS Biology 18 (10), e3000903, 2020
212020
CDK2 kinase activity is a regulator of male germ cell fate
P Singh, RK Patel, N Palmer, JK Grenier, D Paduch, P Kaldis, A Grimson, ...
Development 146 (21), dev180273, 2019
202019
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity
D Katrekar, Y Xiang, N Palmer, A Saha, D Meluzzi, P Mali
Elife 11, e75555, 2022
192022
Exploring protein orthogonality in immune space: a case study with AAV and Cas9 orthologs
AM Moreno, N Palmer, F Alemán, G Chen, A Pla, WL Chew, M Law, ...
BioRxiv, 245985, 2018
142018
The CDK1-TOPBP1-PLK1 axis regulates the Bloom’s syndrome helicase BLM to suppress crossover recombination in somatic cells
C Balbo Pogliano, I Ceppi, S Giovannini, V Petroulaki, N Palmer, F Uliana, ...
Science Advances 8 (5), eabk0221, 2022
112022
CDK2 regulates the NRF1/Ehmt1 axis during meiotic prophase I
N Palmer, SZA Talib, CK Ratnacaram, D Low, X Bisteau, JHS Lee, ...
Journal of Cell Biology 218 (9), 2896-2918, 2019
112019
The Econ-ARK and HARK: Open Source Tools for Computational Economics.
CD Carroll, AM Kaufman, JL Kazil, NM Palmer, MN White
SciPy, 25-30, 2018
102018
Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors
KM Ford, R Panwala, DH Chen, A Portell, N Palmer, P Mali
Cell systems 12 (7), 716-732. e7, 2021
92021
NF-κB as a Potential Molecular Target for Therapy of Gastrointestinal Cancers
N Palmer, MK Shanmugam, G Sethi, P Kaldis
Therapeutic targets for inflammation and cancer: Novel therapies for …, 2017
42017
568P First-in-human anti-ALPP CAR-T cell immunotherapy for ovarian and endometrial cancer
B Zhu, Q Jia, R Chen, G Chen, L Zhao, N Palmer, D Xiang, F Chen, ...
Annals of Oncology 33, S807, 2022
32022
Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA base-editing activity, functionality and specificity
D Katrekar, N Palmer, Y Xiang, A Saha, D Meluzzi, P Mali
Biorxiv, 2020.09. 08.288233, 2020
32020
The system can't perform the operation now. Try again later.
Articles 1–20